Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT03893500
Utility of Device and App-based Mobile Health Monitoring as a Tool for Evaluation of Clinical Response to Therapies in Pulmonary Arterial Hypertension
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Inclusion Criteria:
- Diagnosis of WHO Group I Pulmonary Arterial Hypertension (PAH) (Idiopathic (I)PAH,
Heritable PAH (including Hereditary Hemorrhagic Telangiectasia), Associated (A)PAH
(including collagen vascular disorders, drugs+toxins exposure, congenital heart
disease, and portopulmonary disease).
- Do not meet exclusion criteria
Exclusion Criteria:
- Pulmonary Hypertension due to left heart disease (PH-LHD, WHO group 2), Pulmonary
hypertension due to chronic lung disease (PH-CLD, WHO group 3), Chronic
thrombo-embolic pulmonary hypertension (CTEPH, WHO group 4), pulmonary hypertension
with unclear and/or multi-factorial mechanisms (WHO goup 5)
- Inability to perform a 6 minute walk test (6MWT)
device: Home-based 6 minute walk test
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alejandra Elizabeth Lopez